⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7554361 | 0.95 | — | — | |
| SCHEMBL29040693 | 0.79 | — | — | |
| SCHEMBL10974790 | 0.73 | — | — | |
| SCHEMBL75645 | 0.73 | — | — | |
| SCHEMBL22368314 | 0.73 | — | — | |
| SCHEMBL22149127 | 0.73 | — | — | |
| SCHEMBL28345952 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL221036 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL20703229 | 0.68 | — | — | |
| SCHEMBL858259 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0943609-B1 | Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof | TOA PHARMACEUTICAL CO LTD (JP) | 2002-07-03 | — | — | EP | claimed |
| US-6063935-A | CULTIVATING A BACTERIA OF A BACILLUS GENUS CAPABLE OF PRODUCING 3,3-DIHYDROXYAZETIDINE OR SALT THEREOF TO PRODUCE THE 3,3-DIHYDROXYAZETIDINE OR SALT IN CULTURE MEDIUM AND COLLECTING THE PRODUCT | TOA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-16 | — | — | US | claimed |
| EP-0943609-A1 | Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof | Toa Pharmaceutical Co., Ltd. (JP) | 1999-09-22 | — | — | EP | claimed |
| CN-1229076-A | Trimethlene imidic derivant and composition for promoting two-tailed bacterium division using the derivant as active principle and making method thereof | TOA PHARMACEUTICAL CO LTD (JP) | 1999-09-22 | — | — | CN | claimed |
| JP-11269142-A | — | — | None | — | — | JP | disclosed |
| CN-105263914-B | biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders | 艾尼纳制药公司 | 2017-10-27 | — | — | CN | disclosed |
| EP-2498780-B1 | N-9-SUBSTITUTED PURINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2016-09-07 | — | — | EP | disclosed |
| EP-0943609-B1 | Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof | TOA PHARMACEUTICAL CO LTD (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-6063935-A | CULTIVATING A BACTERIA OF A BACILLUS GENUS CAPABLE OF PRODUCING 3,3-DIHYDROXYAZETIDINE OR SALT THEREOF TO PRODUCE THE 3,3-DIHYDROXYAZETIDINE OR SALT IN CULTURE MEDIUM AND COLLECTING THE PRODUCT | TOA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-16 | — | — | US | disclosed |
| US-6063935-A | CULTIVATING A BACTERIA OF A BACILLUS GENUS CAPABLE OF PRODUCING 3,3-DIHYDROXYAZETIDINE OR SALT THEREOF TO PRODUCE THE 3,3-DIHYDROXYAZETIDINE OR SALT IN CULTURE MEDIUM AND COLLECTING THE PRODUCT | TOA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-16 | — | — | US | disclosed |
| JP-H11269142-A | AZETIDINE DERIVATIVE, BIFIDOBACTERIUM CELL DIVISION-PROMOTING COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT AND ITS PRODUCTION | TOA YAKUHIN KOGYO KK | 1999-10-05 | — | — | JP | disclosed |
| EP-0943609-A1 | Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof | Toa Pharmaceutical Co., Ltd. (JP) | 1999-09-22 | — | — | EP | disclosed |
| EP-0943609-A1 | Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof | Toa Pharmaceutical Co., Ltd. (JP) | 1999-09-22 | — | — | EP | disclosed |
| CN-1229076-A | Trimethlene imidic derivant and composition for promoting two-tailed bacterium division using the derivant as active principle and making method thereof | TOA PHARMACEUTICAL CO LTD (JP) | 1999-09-22 | — | — | CN | disclosed |
| CN-1229076-A | Trimethlene imidic derivant and composition for promoting two-tailed bacterium division using the derivant as active principle and making method thereof | TOA PHARMACEUTICAL CO LTD (JP) | 1999-09-22 | — | — | CN | disclosed |